Argus•April 07, 2021

NKTR: Lowering target price to $16.00

Symbols

Sector(s)

Healthcare

Rating

Current Price

$1.38

Price Target

Earnings Estimate

Summary

Nektar Therapeutics is a San Francisco-based emerging biotechnology company specializ

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level